GGrantIndex
Sort

48,018 grants matching immunotherapy

Developing whole-body computational phantoms for blood dosimetry to model the impact of radiation on the immune system

$457,005
Harald Paganetti · Massachusetts General Hospital · R01 · FY2024 · CA

Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy

$457,001
Anand T.n. Kumar · Massachusetts Eye And Ear Infirmary · R01 · FY2025 · CA

Targeting Post-Transplant Minimal Residual CD19+ ALL with Genetically-

$456,968
Laurence J.n. Cooper · Beckman Research Institute/City Of Hope · P01 · FY2008 · CA

Novel multipronged Immunovirotherapy Approach for GBM Treatment

$456,968
Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2023 · CA

DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY

$456,897
Robert David Schreiber · Washington University · R01 · FY2017 · CA

Lymph node-targeted multistage chemoimmunotherapy for lymphoma

$456,887
Susan Napier Thomas · Georgia Institute Of Technology · R01 · FY2024 · CA

Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy

$456,823
Paul Michael Armistead · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA

MRI of tumor-infiltrating lymphocytes using MRI-cytometry

$456,808
Junzhong Xu · Vanderbilt University Medical Center · R01 · FY2023 · CA

Research Training in Academic Medical Oncology

$456,767
Richard E. Champlin · University Of Tx Md Anderson Can Ctr · T32 · FY2015 · CA

Project 1: Promoting Graft-versus-Tumor Effects in the Bone Marrow

$456,745
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2025 · CA

Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment

$456,744
Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA

Enhancing HSPC CAR-mediated immunity in vivo

$456,689
Scott G Kitchen · University Of California Los Angeles · U19 · FY2021 · AI

Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma

$456,635
Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA

Leveraging Zika virus and the immune system to treat glioblastoma

$456,534
Milan Girish Chheda · Washington University · R01 · FY2023 · NS

Project 2: Understanding the Cellular Origins of Melanoma

$456,525
Anand K Ganesan · University Of California-Irvine · U54 · FY2020 · CA

Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)

$456,475
Xueding Wang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Deciphering the specificity and molecular mechanisms of regulatory T cells using novel approaches

$456,471
Billur Akkaya · Ohio State University · DP2 · FY2025 · AI

Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma

$456,361
Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA

An interactive analysis toolkit for single cell RNA-seq in cancer research

$456,340
William Evan Johnson · Boston University Medical Campus · U01 · FY2019 · CA

Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors

$456,302
Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2021 · AI

Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors

$456,302
Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2024 · AI

Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors

$456,302
Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2023 · AI

(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome

$456,293
Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma

$456,286
Xiao-Fan Wang · Duke University · R01 · FY2020 · CA

Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics

$456,274
Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2019 · NS